Bango, King Robert .

HRN: 22-34-93  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2022
AMPICILLIN 250MG (VIAL)
12/21/2022
12/27/2022
IVT
70mg
Q12
Sepsis
Waiting Final Action 
12/21/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
12/21/2022
12/27/2022
IVT
7mg
OD
Sepsis
Waiting Final Action 
12/21/2022
CEFTAZIDIME 1GM (VIAL)
12/21/2022
12/28/2022
IV
42 Mg
Q8
PSNB; Prematurity
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: